The abundance of mechanisms by which transformed cells can deregulate CDK4/6 activity suggests this enzyme is crucial for cancer pathogenesis and inhibiting CDK4/6 activity has the potential to be therapeutically beneficial. The gene discussed is CDK4; the disease is cancer.